SIAPS Quarterly Report: Year 4 Quarter 4

The program's goal is to improve governance, build capacity for pharmaceutical management and services, address information needed for decision-making in the pharmaceutical sector, strengthen financing strategies and mechanisms to improve access to medicines, and increase quality pharmaceutical services. SIAPS has made significant progress in strengthening pharmaceutical sector governance, with a focus on improving regulatory frameworks, enhancing the capacity of national regulatory authorities, and promoting transparency and accountability in the pharmaceutical sector. The program has also made substantial contributions to building capacity for pharmaceutical supply management and services, including the development of logistics management information systems and the implementation of electronic dispensing tools. In addition, SIAPS has increased the utilization of information for decision-making in the pharmaceutical sector, including the development of data management systems and the implementation of monitoring and evaluation frameworks. The program has also strengthened financing strategies and mechanisms to improve access to medicines, including the development of national essential medicines lists and the implementation of price controls. SIAPS has also made significant progress in improving supply chain management, including the implementation of auditable pharmaceutical transactions and services systems and the development of emergency medicines funds. The program has also improved pharmaceutical services to achieve desired outcomes, including the implementation of integrated management of childhood illness programs and the development of electronic dispensing tools. The program has also made significant contributions to improving maternal, neonatal, and child health outcomes, including the implementation of family planning programs and the development of maternal and child health guidelines. SIAPS has also worked to strengthen the capacity of national regulatory authorities, including the development of regulatory frameworks and the implementation of training programs for healthcare workers. In terms of geographic focus, SIAPS has worked in over 20 countries, including Angola, Bangladesh, Burundi, Cameroon, Democratic Republic of the Congo, Dominican Republic, Ethiopia, Guinea, Haiti, Lesotho, Mali, Mozambique, Namibia, Niger, Philippines, South Africa, South Sudan, Swaziland, Tajikistan, Turkmenistan, Ukraine, and Uzbekistan. The program has also worked with various global partners, including the US Centers for Disease Control and Prevention, the Clinton Health Access Initiative, and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Overall, SIAPS has made significant contributions to improving access to quality pharmaceutical products and services, and has helped to strengthen the capacity of national regulatory authorities and healthcare systems in over 20 countries. The program's progress has been significant, and it continues to play a critical role in improving health outcomes and reducing the burden of disease in low- and middle-income countries.